Clinical Trials Directory

Trials / Unknown

UnknownNCT01810809

Hip Viscosupplementation: What is the Best Dosage?

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Intraarticular injections have long been used to treat osteoarthritis. Viscosupplementation is a relatively new approach comprising the injection of hyaluronic acid into diarthrodial joints. The dosis regimen is well established for the knee joint, but there is still no consensus regarding the optimal dosage for hip viscosupplementation. Our objective is to determine the optimal dosis for hip viscosupplementation

Detailed description

Intraarticular injections have long been used to treat osteoarthritis. Viscosupplementation is a relatively new approach comprising the injection of hyaluronic acid into diarthrodial joints. Any osteoarthritic joint is eligible to this treatment modality, but the great majority of studies are for knee viscosupplementation. The dosis regimen is well established for the knee joint, but there is still no consensus regarding the optimal dosage for hip viscosupplementation. We will prospectively enroll 80 patients with hip osteoarthritis and will randomize them into four groups: Group zero will receive joint lavage with saline injection. Group 1 will receive joint lavage with saline injection and 2 ml of Hylan GF-20 (1 ampoule of Synvisc Classic®). Group 2 will receive joint lavage with saline injection and 4 ml of Hylan GF-20 (2 ampoules of Synvisc Classic®). Group 3 will receive joint lavage with saline injection and 6 ml of Hylan GF-20 (3 ampoules of Synvisc Classic®). The Visual Analogic Scale of Pain (VAS), the Western Ontario and McMaster Universities Index (WOMAC®), and Lequesne questionnaires were completed at baseline and at Weeks 1, 4, 12, and 24. Our objective is to determine the optimal dosis for hip viscosupplementation

Conditions

Interventions

TypeNameDescription
PROCEDUREarticular lavage with saline injectionPatients will receive articular lavage with saline injection
DRUG1 ampoule of Hylan GF-20Patients will receive viscosupplementation with 2ml (1 ampoule) of Hylan GF-20
DRUG2 ampoules of Hylan GF-20Patients will receive viscosupplementation with 4ml (2 ampoules) of Hylan GF-20
DRUG3 ampoules of Hylan GF-20Patients will receive viscosupplementation with 6ml (3 ampoules) of Hylan GF-20

Timeline

Start date
2013-04-01
Primary completion
2014-06-01
Completion
2014-11-01
First posted
2013-03-14
Last updated
2013-09-11

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01810809. Inclusion in this directory is not an endorsement.